A clinical case of acquired form of thrombotic thrombocytopenic purpura. Description and treatment
Abstract
About the Authors
D. K. NovikRussian Federation
A. V. Denisov
Russian Federation
E. M. Repchenko
Russian Federation
D. V. Kravchenko
Russian Federation
S. G. Kuzniatsou
Russian Federation
S. A. Khadanovich
Russian Federation
References
1. Филатов, Л.Б. Тромботическая тромбоцитопеническая пурпура (болезнь Мошковица) / Л.Б. Филатов // Редкие гематологические болезни и синдромы. Под ред. М.А. Волковой. - М.: Практическая медицина, 2011. - С. 32-51.
2. Moschcowitz, E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease / E. Moschcowitz // Mount Sinai J. Med. - 2003. - 70 (5). - Р. 353- 355.
3. Singer, K. Thrombotic thrombocytopenic purpura: hemorrhagic diathesis with generalized platelet thrombosis / K. Singer, F.P. Bornstein, S.A. Wile // Blood. - 1947. - Vol. 2 (6). - Р. 542-554.
4. George, J.N. Thrombotic thrombocytopenic purpura /j.N. George // N. Engl. J. Med. - 2006. - 354 (18). - P. 1927- 3519.
5. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura /j.L. Moake [et al.] // N. Engl. J. Med. - 1982. - Vol. 307(23). - 1432-1435.
6. Moake, J.L. Idiopathic thrombotic thrombocytopenia purpura/ in: Recent advances in thrombotic thrombocytopenic purpura /j.L. Moake // Hematology. - 2004. - P. 407-423.
7. Von Willebrand factor - cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome / M. Furlan [et al.] // N. Engl. J. Med. - 1998. - Vol. 339(22). - P. 1578-1584.
8. Prognostic value of anti-ADAMTS-13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS-13 activity / S. Ferrari [et al.] // Blood. - 2007. - Vol. 109(7). - P. 2815-2822.
9. Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS-13 secretion / M. Underwood [et al.] // Thrombosis research. - 2016. - Vol. 147. - P. 16-23.
10. Tsai, H.-M. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura / H.- M. Tsai, E.Ch.-Y. Lian // N. Engl. J. Med. - 1998. - Vol. 339(22). - P. 1585-1594.
11. George, J.N. Platelets: thrombotic thrombocytopenic purpura /j.N. George, J.E. Sadler, B. Lämmle // Hematology. - 2002. No 1. - P. 315-334.
12. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura / F. Peyvandi [et al.] // Br J Haematol. - 2004. - Vol. 127. - P. 433-439.
13. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura / G.G. Levy [et al.] // Nature. - 2001. - Vol. 413. - P. 488-494.
14. George, J.N. Forecasting the future for patients with hereditary TTP /j.N. George // Blood. - 2012. - Vol. 120(2). - P. 243-244.
15. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome / G. Remuzzi [et al.] // Blood. - 2002. - Vol. 100(10). - P. 778-785.
Review
For citations:
Novik D.K., Denisov A.V., Repchenko E.M., Kravchenko D.V., Kuzniatsou S.G., Khadanovich S.A. A clinical case of acquired form of thrombotic thrombocytopenic purpura. Description and treatment. Medical and Biological Problems of Life Activity. 2019;(2):124-128. (In Russ.)